Xerofree 40 Mg Injection
150 INR/Piece
Product Details:
- Pacakaging (Quantity Per Box) 1 Injection (Prefilled Syringe)
- Indication Treatment and prevention of thromboembolic disorders
- Dosage Form Injection (prefilled syringe)
- Origin of Medicine Allopathic
- Salt Composition Enoxaparin Sodium 40 mg/0.4 ml
- Drug Type Prescription
- Ingredients Enoxaparin Sodium
- Click to View more
X
Xerofree 40 Mg Injection Price And Quantity
- 1 Piece
- 150 INR/Piece
- Subcutaneous
- 24 months from date of manufacture
- Clear, colorless to pale yellow solution
- Not for intramuscular use, use with caution in patients with bleeding disorders
- 40 mg/0.4 ml
- Bleeding, thrombocytopenia, injection site reactions
- Prefilled Syringe in a sealed box
- As per packaging
- To be used only under medical supervision
- Hospital and clinical use
- Xerofree 40 Mg Injection
- Yes
- Active major bleeding, hypersensitivity to enoxaparin or heparin
Xerofree 40 Mg Injection Product Specifications
- Anticoagulant (blood thinner)
- Store below 25C, protect from light. Do not freeze.
- Prescription
- Treatment and prevention of thromboembolic disorders
- Inject subcutaneously, as prescribed by the healthcare provider
- 1 Injection (Prefilled Syringe)
- Prevention of Deep Vein Thrombosis (DVT), Pulmonary Embolism, and treatment of acute coronary syndrome
- Enoxaparin Sodium
- Adults
- Allopathic
- Enoxaparin Sodium 40 mg/0.4 ml
- As directed by the physician
- Injection
- 1 Vial
- Injection (prefilled syringe)
- Subcutaneous
- 24 months from date of manufacture
- Clear, colorless to pale yellow solution
- Not for intramuscular use, use with caution in patients with bleeding disorders
- 40 mg/0.4 ml
- Bleeding, thrombocytopenia, injection site reactions
- Prefilled Syringe in a sealed box
- As per packaging
- To be used only under medical supervision
- Hospital and clinical use
- Xerofree 40 Mg Injection
- Yes
- Active major bleeding, hypersensitivity to enoxaparin or heparin
Product Description
Product introduction
Xerofree Injection is an anticoagulant used to prevent and treat harmful blood clots. It stops the existing clots from getting any bigger and restricts the formation of any new clot. It is also helpful in the prevention of blood clots in veins, a condition called deep vein thrombosis, and pulmonary embolism.
Xerofree Injection is injected under the skin by a doctor or nurse. It should not be injected into a muscle. The dose and length of treatment are based on your medical condition, your response to the medicine, and what you are being treated for. It may also be based on your age and weight. It is important to keep using this medicine even if you do not notice any symptoms because it is preventing future harm. If you stop taking it, you could get a blood clot. While taking this medicine you should avoid doing things that increase your risk of bleeding or injury.
Effective Thromboprophylaxis
Xerofree 40 Mg Injection is primarily recommended for the prevention and treatment of thromboembolic disorders, such as deep vein thrombosis and pulmonary embolism. By interfering with blood clot formation, it plays an essential role in minimizing the risks associated with immobility, surgery, or acute coronary syndrome in adults, contributing to better overall health outcomes.
Precise Subcutaneous Administration
The injection is designed for subcutaneous use only, ensuring targeted delivery and optimal absorption of Enoxaparin Sodium. The prefilled syringe allows for controlled dosing under a healthcare provider's guidance, reducing the potential for handling errors and enhancing safety, particularly in hospital and clinical environments.
Strict Safety Standards and Storage
Xerofree 40 Mg Injection is supplied in a sterile prefilled syringe to maintain product integrity. It must be stored below 25C and protected from light. The solution should always appear clear to pale yellow; if discoloration or particulates are observed, it should not be used. Proper storage and administration are crucial to preserving its efficacy.
FAQ's of Xerofree 40 Mg Injection:
Q: How should Xerofree 40 Mg Injection be administered?
A: Xerofree 40 Mg Injection must be injected subcutaneously, preferably by a trained healthcare professional in a hospital or clinical setting. It should never be administered intramuscularly. The precise dose and frequency will be determined by your physician, based on your medical condition.Q: What conditions is Xerofree 40 Mg Injection recommended for?
A: This injection is indicated for the prevention and treatment of deep vein thrombosis (DVT), pulmonary embolism, and acute coronary syndrome. It acts as an anticoagulant to reduce the risk of potentially dangerous blood clots in adults.Q: When should Xerofree 40 Mg Injection not be used?
A: Xerofree should not be used in patients with active major bleeding, a known hypersensitivity to enoxaparin, heparin, or pork products. It is contraindicated if you have any of these conditions. Always inform your physician of your full medical history before administration.Q: Where should Xerofree 40 Mg Injection be stored before use?
A: This medication should be stored in its original sealed box below 25C, away from direct light. It should never be frozen. Ensure the solution is clear and colorless to pale yellow before use-do not use it if cloudy or contains particles.Q: What are the benefits of using Xerofree 40 Mg Injection?
A: Xerofree offers effective prevention and treatment of blood clots, reducing the risk of complications such as DVT and pulmonary embolism. Its prefilled syringe design allows accurate dosing and enhanced safety in clinical settings.Q: What are the possible side effects of Xerofree 40 Mg Injection?
A: Common side effects include minor bleeding, thrombocytopenia (low blood platelets), and local reactions at the injection site. If you experience any signs of unusual or severe bleeding, notify your healthcare provider immediately.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anticoagulant and Antiplatelet Drugs' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
